ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 1320

$439K Total Retail Price of All Prescriptions

Rank: 211 out of 1320

539 Patients Receiving at Least One Drug in Part D
77% Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arizona
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 423 304 85 1 1
HYDROCODONE-ACETAMINOPHEN 423 242 74 S3 1 7
LEVOTHYROXINE SODIUM 395 327 80 3 2
METFORMIN HCL 245 204 48 4 5
AMLODIPINE BESYLATE 216 194 49 5 4
ZOLPIDEM TARTRATE 211 159 41 6 17
SIMVASTATIN 196 172 50 7 3
ALPRAZOLAM 165 95 36 B 8 26
CARISOPRODOL 140 48 20 R 9 66
FLUTICASONE PROPIONATE 136 94 61 10 20
AZITHROMYCIN 133 105 107 11 42
OXYCODONE-ACETAMINOPHEN 128 70 39 S2 12 40
OMEPRAZOLE 127 79 29 13 6
OXYCODONE HCL-ACETAMINOPHEN 124 78 16 S2 14 73
HYDROCHLOROTHIAZIDE 123 88 28 15 9
LOVASTATIN 122 93 25 16 16
CLONAZEPAM 122 55 21 B 16 57
METOPROLOL TARTRATE 107 82 16 18 10
NAPROXEN 107 81 50 18 78
FUROSEMIDE 107 73 25 18 11
CIPROFLOXACIN HCL 106 88 68 21 52
TEMAZEPAM 103 90 24 B 22 53
OXYCODONE HCL 99 25 27 S2 23 29
GABAPENTIN 93 38 18 24 12
ESCITALOPRAM OXALATE 90 59 19 25 76
CLOPIDOGREL 89 67 17 26 27
ALLOPURINOL 89 84* 24 26 37
ATENOLOL 83 78* 17 28 13
MORPHINE SULFATE ER 83 30 14 S2 28 43
ATORVASTATIN CALCIUM 81 76* 17 30 8
LORAZEPAM 81 60 29 B 30 31
CITALOPRAM HBR 79 64 16 32 23
DIAZEPAM 74 33 19 B 33 83
ESTRADIOL 72 48 15 R 34 79
CRESTOR 69 <11 <11 35 35
ROPINIROLE HCL 68 <11 <11 36 116
LOSARTAN POTASSIUM 67 67 14 37 14
PANTOPRAZOLE SODIUM 62 45 14 38 33
OXYCONTIN 62 <11 <11 S2 38 106
TAMSULOSIN HCL 56 40 13 40 30
PROAIR HFA 56 28 21 40 28
ACYCLOVIR 56 <11 <11 40 133
DONEPEZIL HCL 53 <11 <11 43 47
CEPHALEXIN 51 33 33 44 75
POTASSIUM CHLORIDE 50 26 14 45 19
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.